The Center for Biologics Evaluation and Research (CBER) is one of five main centers for the Food and Drug Administration, which is in the United States Department of Health and Human Services. CBER is responsible for assuring the safety, purity, potency, and effectiveness of biological products such as:

• Blood and blood products.
• Cells and tissues for transplant.
• Vaccines.
• Gene therapy.CBER websit, CBER's Vision and Mission: ^*

Authority

---

As of July 2006 CBER's authority resides in section 351 of the Public Health Service Act and in various sections of the Food, Drug and Cosmetic Act.CBER website, About CBER:^*

At the CBER's Vaccines and Related Biological Products Advisory Committee's 101st meeting of February 16, 2005, an extensive discussion and vote was held concerning next year's flu vaccine virus selection. (transcript of U.S. FDA Center for Biologics Evaluation and Research Vaccines and Related Biological Products Advisory Committee's 101st meeting of February 16, 2005 is here: origin.www.fda.gov in .DOC format in Google provided HTML format)

Further reading

---

• CBER home page
• CBER FY 2004 Annual Report

Sources

---

1902 establishments | Food and Drug Administration | Influenza | Vaccination